These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 25749987

  • 21. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
    Fang L, Tang B, Hou D, Meng M, Xiong M, Yang J.
    BMC Nephrol; 2015 Jun 10; 16():82. PubMed ID: 26058796
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M, Tanaka K, Marui Y, Tomikawa S.
    Ther Apher Dial; 2013 Oct 10; 17(5):551-6. PubMed ID: 24107283
    [Abstract] [Full Text] [Related]

  • 28. Atypical spindle cell lesions in secondary parathyroid hyperplasia.
    Masuda A, Nishikawa T, Yamamoto T, Aiba M, Kobayashi M.
    Histopathology; 2008 Feb 10; 52(3):402-4. PubMed ID: 18269591
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism.
    Gogusev J, Duchambon P, Stoermann-Chopard C, Giovannini M, Sarfati E, Drüeke TB.
    Nephrol Dial Transplant; 1996 Nov 10; 11(11):2155-62. PubMed ID: 8941573
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
    Martins P, Schmitt F, Almeida H, Frazão JM.
    Nephrol Dial Transplant; 2008 Sep 10; 23(9):2889-94. PubMed ID: 18398016
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T.
    Kidney Int; 2010 Feb 10; 77(3):211-8. PubMed ID: 20016468
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Kakuta T, Tanaka R, Kanai G, Miyamoto Y, Inagaki M, Suzuki H, Fukagawa M, Saito A.
    Ther Apher Dial; 2008 Oct 10; 12(5):385-90. PubMed ID: 18937722
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN, Kayath MJ, Vieira JG, Nosé-Alberti V.
    Histopathology; 1998 Jul 10; 33(1):46-51. PubMed ID: 9726048
    [Abstract] [Full Text] [Related]

  • 39. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB.
    N Engl J Med; 1987 Jun 18; 316(25):1573-7. PubMed ID: 3035373
    [Abstract] [Full Text] [Related]

  • 40. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB.
    Endocrinology; 2012 Apr 18; 153(4):1627-37. PubMed ID: 22334717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.